Catalyst Wire Dossier Catalyst Wire Dossier

Briakinumab

briakinumab · Abbott
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Briakinumab, covering 2011-10-21 to 2011-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates. [Phase 1]

See pricing